Exforge HCT and Breastfeeding

At this time, it is unknown whether Exforge HCT (amlodipine-valsartan-hydrochlorothiazide) is safe for nursing women or their infants. One component of the drug is known to pass through breast milk, but low doses do not appear to cause any problems for nursing infants. Breastfeeding women should consult their healthcare providers before taking Exforge HCT.

Exforge HCT Medication Information

Is Exforge HCT Safe for Breastfeeding Women?

Exforge HCT^® (amlodipine-valsartan-hydrochlorothiazide) is a prescription medication used to treat high blood pressure. It contains amlodipine (Norvasc^®), valsartan (Diovan^®), and hydrochlorothiazide. It is not clear if this drug is safe for breastfeeding women. Therefore, you should talk with your healthcare provider before taking it if you are breastfeeding or plan to start.

Breastfeeding Information

Hydrochlorothiazide passes through breast milk, although doses below 50 mg per day are not thought to cause any problems (this is higher than the highest strength of hydrochlorothiazide in Exforge HCT). Higher doses may suppress breast milk production.

No research has been done to see if the other two active ingredients in Exforge HCT pass through breast milk. The manufacturer of Exforge HCT warns against taking this medication while breastfeeding.

Talking With Your Healthcare Provider About Breastfeeding and Exforge HCT

You should talk with your healthcare provider about taking this drug while breastfeeding.

Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.